Lexeo Therapeutics, Inc. short interest in 2025
In 2025, Lexeo Therapeutics, Inc.'s disclosed short interest ran from 7.00% of shares outstanding on 15 Jan 2025 to 14.84% on 31 Dec 2025, a change of +7.84 percentage points. The year's high was 15.81% on 31 Jul 2025 and its low 5.68% on 31 Jan 2025, averaging 10.31% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.15 days on 15 Aug 2025. Full history: Lexeo Therapeutics, Inc..
Cite this page
2025 in figures
- Start of year
- 7.00% (15 Jan 2025)
- End of year
- 14.84% (31 Dec 2025)
- Change
- +7.84 pp
- High
- 15.81% (31 Jul 2025)
- Low
- 5.68% (31 Jan 2025)
- Average
- 10.31%
- Highest days to cover
- 18.15 (15 Aug 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 7.00% | 10.73 | |
| 31 Jan 2025 | 5.68% | 7.84 | |
| 14 Feb 2025 | 6.99% | 7.47 | |
| 28 Feb 2025 | 7.36% | 6.32 | |
| 14 Mar 2025 | 6.70% | 3.70 | |
| 31 Mar 2025 | 7.77% | 2.20 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 8.85% | 2.09 | |
| 30 Apr 2025 | 9.83% | 4.91 | |
| 15 May 2025 | 9.38% | 2.72 | 10-Q filed, results (8-K) |
| 30 May 2025 | 11.39% | 4.65 | |
| 13 Jun 2025 | 14.41% | 6.24 | |
| 30 Jun 2025 | 15.51% | 8.92 | |
| 15 Jul 2025 | 15.60% | 12.03 | |
| 31 Jul 2025 | 15.81% | 10.59 | |
| 15 Aug 2025 | 9.79% | 18.15 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 9.69% | 16.93 | |
| 15 Sep 2025 | 10.91% | 10.96 | |
| 30 Sep 2025 | 11.04% | 6.24 | |
| 15 Oct 2025 | 13.55% | 4.66 | |
| 31 Oct 2025 | 9.60% | 3.97 | results (8-K) |
| 14 Nov 2025 | 7.72% | 3.44 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 8.27% | 5.76 | |
| 15 Dec 2025 | 9.73% | 7.21 | |
| 31 Dec 2025 | 14.84% | 5.85 |
See also: Lexeo Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.